Aankondiging • Apr 11
UNID Company Ltd. to Report Q1, 2026 Results on Apr 22, 2026 UNID Company Ltd. announced that they will report Q1, 2026 results on Apr 22, 2026 Reported Earnings • Mar 14
Full year 2025 earnings: Revenues exceed analysts expectations while EPS lags behind Full year 2025 results: EPS: ₩9,830 (down from ₩11,483 in FY 2024). Revenue: ₩1.34t (up 20% from FY 2024). Net income: ₩65.3b (down 14% from FY 2024). Profit margin: 4.9% (down from 6.9% in FY 2024). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 1.5%. Earnings per share (EPS) missed analyst estimates by 10%. Revenue is forecast to grow 9.8% p.a. on average during the next 2 years, compared to a 10% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, earnings per share has increased by 6% per year whereas the company’s share price has increased by 5% per year. Aankondiging • Jan 12
UNID Company Ltd. to Report Q4, 2025 Results on Jan 26, 2026 UNID Company Ltd. announced that they will report Q4, 2025 results on Jan 26, 2026 Price Target Changed • Dec 03
Price target decreased by 8.5% to ₩100,333 Down from ₩109,667, the current price target is an average from 6 analysts. New target price is 52% above last closing price of ₩65,900. Stock is up 5.1% over the past year. The company is forecast to post earnings per share of ₩10,899 for next year compared to ₩11,483 last year. Reported Earnings • Nov 16
Third quarter 2025 earnings released: EPS: ₩2,535 (vs ₩2,988 in 3Q 2024) Third quarter 2025 results: EPS: ₩2,535 (down from ₩2,988 in 3Q 2024). Revenue: ₩329.0b (up 14% from 3Q 2024). Net income: ₩16.8b (down 15% from 3Q 2024). Profit margin: 5.1% (down from 6.8% in 3Q 2024). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 6.9% p.a. on average during the next 3 years, compared to a 12% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, earnings per share has fallen by 7% per year but the company’s share price has fallen by 13% per year, which means it is performing significantly worse than earnings. Aankondiging • Oct 14
UNID Company Ltd. to Report Q3, 2025 Results on Oct 27, 2025 UNID Company Ltd. announced that they will report Q3, 2025 results on Oct 27, 2025 Major Estimate Revision • Oct 01
Consensus EPS estimates fall by 11% The consensus outlook for fiscal year 2025 has been updated. 2025 EPS estimate fell from ₩13,833 to ₩12,333 per share. Revenue forecast steady at ₩1.30b. Net income forecast to grow 24% next year vs 48% growth forecast for Chemicals industry in South Korea. Consensus price target down from ₩116,600 to ₩112,600. Share price fell 4.5% to ₩70,600 over the past week. Reported Earnings • Aug 16
Second quarter 2025 earnings released: EPS: ₩3,581 (vs ₩4,089 in 2Q 2024) Second quarter 2025 results: EPS: ₩3,581 (down from ₩4,089 in 2Q 2024). Revenue: ₩340.9b (up 17% from 2Q 2024). Net income: ₩23.8b (down 12% from 2Q 2024). Profit margin: 7.0% (down from 9.3% in 2Q 2024). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 5.9% p.a. on average during the next 3 years, compared to a 10% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, earnings per share has fallen by 18% per year whereas the company’s share price has fallen by 15% per year. Aankondiging • Jul 09
UNID Company Ltd. to Report Q2, 2025 Results on Jul 23, 2025 UNID Company Ltd. announced that they will report Q2, 2025 results on Jul 23, 2025 Valuation Update With 7 Day Price Move • Apr 14
Investor sentiment improves as stock rises 18% After last week's 18% share price gain to ₩81,600, the stock trades at a forward P/E ratio of 6x. Average forward P/E is 9x in the Chemicals industry in South Korea. Total loss to shareholders of 43% over the past three years. Aankondiging • Apr 09
UNID Company Ltd. to Report Q1, 2025 Results on Apr 23, 2025 UNID Company Ltd. announced that they will report Q1, 2025 results at 12:00 PM, Korea Standard Time on Apr 23, 2025 Major Estimate Revision • Apr 03
Consensus EPS estimates increase by 10% The consensus outlook for earnings per share (EPS) in fiscal year 2025 has improved. 2025 revenue forecast increased from ₩1.31b to ₩1.35b. EPS estimate increased from ₩12,717 to ₩14,011 per share. Net income forecast to grow 24% next year vs 31% growth forecast for Chemicals industry in South Korea. Consensus price target of ₩108,800 unchanged from last update. Share price fell 2.8% to ₩74,200 over the past week. Major Estimate Revision • Mar 21
Consensus EPS estimates fall by 11% The consensus outlook for earnings per share (EPS) in fiscal year 2025 has deteriorated. 2025 revenue forecast decreased from ₩1.41b to ₩1.31b. EPS estimate also fell from ₩14,305 per share to ₩12,717 per share. Net income forecast to grow 13% next year vs 28% growth forecast for Chemicals industry in South Korea. Consensus price target of ₩108,800 unchanged from last update. Share price was steady at ₩77,400 over the past week. Reported Earnings • Mar 14
Full year 2024 earnings: EPS and revenues miss analyst expectations Full year 2024 results: EPS: ₩11,483 (up from ₩2,454 in FY 2023). Revenue: ₩1.11t (down 1.9% from FY 2023). Net income: ₩76.2b (up 369% from FY 2023). Profit margin: 6.9% (up from 1.4% in FY 2023). The increase in margin was driven by lower expenses. Revenue missed analyst estimates by 2.9%. Earnings per share (EPS) also missed analyst estimates by 2.6%. Revenue is forecast to grow 7.4% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, earnings per share has fallen by 46% per year but the company’s share price has only fallen by 15% per year, which means it has not declined as severely as earnings. Aankondiging • Feb 06
UNID Company Ltd., Annual General Meeting, Mar 20, 2025 UNID Company Ltd., Annual General Meeting, Mar 20, 2025, at 10:00 Tokyo Standard Time. Location: conference room, 19, eulji-ro 5-gil, jung-gu, seoul South Korea Price Target Changed • Jan 22
Price target decreased by 9.0% to ₩113,167 Down from ₩124,400, the current price target is an average from 6 analysts. New target price is 67% above last closing price of ₩67,700. Stock is down 0.7% over the past year. The company is forecast to post earnings per share of ₩11,719 for next year compared to ₩2,450 last year. Aankondiging • Jan 15
UNID Company Ltd. to Report Q4, 2024 Final Results on Jan 31, 2025 UNID Company Ltd. announced that they will report Q4, 2024 final results at 12:00 PM, Korea Standard Time on Jan 31, 2025 Valuation Update With 7 Day Price Move • Dec 17
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₩72,700, the stock trades at a forward P/E ratio of 5x. Average forward P/E is 7x in the Chemicals industry in South Korea. Total loss to shareholders of 39% over the past three years. Reported Earnings • Nov 15
Third quarter 2024 earnings released: EPS: ₩2,988 (vs ₩274 loss in 3Q 2023) Third quarter 2024 results: EPS: ₩2,988 (up from ₩274 loss in 3Q 2023). Revenue: ₩289.8b (up 16% from 3Q 2023). Net income: ₩19.8b (up ₩21.7b from 3Q 2023). Profit margin: 6.8% (up from net loss in 3Q 2023). The move to profitability was driven by higher revenue. Revenue is forecast to grow 9.3% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, earnings per share has fallen by 56% per year but the company’s share price has only fallen by 24% per year, which means it has not declined as severely as earnings. Price Target Changed • Oct 23
Price target decreased by 8.6% to ₩117,400 Down from ₩128,400, the current price target is an average from 5 analysts. New target price is 74% above last closing price of ₩67,500. Stock is down 2.0% over the past year. The company is forecast to post earnings per share of ₩12,548 for next year compared to ₩2,450 last year. Buy Or Sell Opportunity • Aug 02
Now 23% undervalued after recent price drop Over the last 90 days, the stock has fallen 14% to ₩83,900. The fair value is estimated to be ₩108,313, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 10% over the last 3 years. Earnings per share has declined by 54%. Revenue is forecast to grow by 18% in 2 years. Earnings are forecast to grow by 185% in the next 2 years. Aankondiging • Jul 17
UNID Company Ltd. to Report Q2, 2024 Results on Jul 24, 2024 UNID Company Ltd. announced that they will report Q2, 2024 results on Jul 24, 2024 Price Target Changed • Jun 08
Price target increased by 14% to ₩118,750 Up from ₩104,333, the current price target is an average from 4 analysts. New target price is 8.2% above last closing price of ₩109,700. Stock is up 66% over the past year. The company is forecast to post earnings per share of ₩13,794 for next year compared to ₩2,450 last year. Valuation Update With 7 Day Price Move • Apr 29
Investor sentiment improves as stock rises 20% After last week's 20% share price gain to ₩97,700, the stock trades at a forward P/E ratio of 7x. Average forward P/E is 10x in the Chemicals industry in South Korea. Total loss to shareholders of 2.0% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩45,300 per share. Major Estimate Revision • Apr 26
Consensus EPS estimates increase by 12% The consensus outlook for fiscal year 2024 has been updated. 2024 EPS estimate increased from ₩10,888 to ₩12,173. Revenue forecast steady at ₩1.11b. Net income forecast to grow 407% next year vs 31% growth forecast for Chemicals industry in South Korea. Consensus price target up from ₩104,333 to ₩107,667. Share price rose 14% to ₩93,200 over the past week. Price Target Changed • Apr 18
Price target increased by 7.9% to ₩104,333 Up from ₩96,667, the current price target is an average from 3 analysts. New target price is 25% above last closing price of ₩83,200. Stock is up 18% over the past year. The company is forecast to post earnings per share of ₩10,888 for next year compared to ₩2,450 last year. Aankondiging • Apr 17
UNID Company Ltd. to Report Q1, 2024 Results on Apr 24, 2024 UNID Company Ltd. announced that they will report Q1, 2024 results on Apr 24, 2024 Valuation Update With 7 Day Price Move • Apr 01
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₩82,300, the stock trades at a forward P/E ratio of 8x. Average forward P/E is 10x in the Chemicals industry in South Korea. Total returns to shareholders of 1.7% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩38,930 per share. Reported Earnings • Mar 23
Full year 2023 earnings: EPS exceeds analyst expectations Full year 2023 results: EPS: ₩2,450 (down from ₩14,220 in FY 2022). Revenue: ₩1.13t (down 19% from FY 2022). Net income: ₩16.3b (down 86% from FY 2022). Profit margin: 1.4% (down from 8.5% in FY 2022). Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 23%. Revenue is forecast to grow 1.5% p.a. on average during the next 2 years, compared to a 13% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, earnings per share has fallen by 42% per year but the company’s share price has only fallen by 6% per year, which means it has not declined as severely as earnings. Upcoming Dividend • Dec 20
Upcoming dividend of ₩2,000 per share at 2.9% yield Eligible shareholders must have bought the stock before 27 December 2023. Payment date: 08 April 2024. The company is not currently making a profit but it is cash flow positive. Trailing yield: 2.9%. Lower than top quartile of South Korean dividend payers (3.5%). Higher than average of industry peers (1.8%). Reported Earnings • Nov 17
Third quarter 2023 earnings released: ₩274 loss per share (vs ₩3,496 profit in 3Q 2022) Third quarter 2023 results: ₩274 loss per share (down from ₩3,496 profit in 3Q 2022). Revenue: ₩250.7b (down 36% from 3Q 2022). Net loss: ₩1.82b (down 106% from profit in 3Q 2022). Revenue is expected to decline by 2.2% p.a. on average during the next 3 years, while revenues in the Chemicals industry in South Korea are expected to grow by 16%. Over the last 3 years on average, earnings per share has fallen by 22% per year but the company’s share price has increased by 10% per year, which means it is well ahead of earnings. Valuation Update With 7 Day Price Move • Nov 03
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to ₩79,200, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 12x in the Chemicals industry in South Korea. Total returns to shareholders of 51% over the past three years. Valuation Update With 7 Day Price Move • Oct 18
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to ₩70,800, the stock trades at a forward P/E ratio of 11x. Average forward P/E is 12x in the Chemicals industry in South Korea. Total returns to shareholders of 32% over the past three years. Major Estimate Revision • Jul 26
Consensus revenue estimates fall by 22% The consensus outlook for revenues in fiscal year 2023 has deteriorated. 2023 revenue forecast decreased from ₩1.48b to ₩1.15b. EPS estimate fell from ₩15,938 to ₩3,887 per share. Net income forecast to shrink 55% next year vs 43% growth forecast for Chemicals industry in South Korea . Consensus price target down from ₩109,000 to ₩79,000. Share price fell 12% to ₩54,100 over the past week. Aankondiging • Jul 24
UNID Company Ltd. to Report Q2, 2023 Results on Jul 25, 2023 UNID Company Ltd. announced that they will report Q2, 2023 results on Jul 25, 2023 Reported Earnings • Mar 10
Full year 2022 earnings released: EPS: ₩14,220 (vs ₩19,247 in FY 2021) Full year 2022 results: EPS: ₩14,220 (down from ₩19,247 in FY 2021). Revenue: ₩1.40t (up 60% from FY 2021). Net income: ₩119.2b (down 29% from FY 2021). Profit margin: 8.5% (down from 19% in FY 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 26% per year whereas the company’s share price has increased by 23% per year. Upcoming Dividend • Dec 21
Upcoming dividend of ₩1,700 per share Eligible shareholders must have bought the stock before 28 December 2022. Payment date: 10 April 2023. Payout ratio is a comfortable 10% but the company is not cash flow positive. Trailing yield: 2.6%. Lower than top quartile of South Korean dividend payers (3.3%). In line with average of industry peers (2.4%). Board Change • Nov 28
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. 2 independent directors (4 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Valuation Update With 7 Day Price Move • Sep 26
Investor sentiment deteriorated over the past week After last week's 19% share price decline to ₩90,500, the stock trades at a trailing P/E ratio of 5.4x. Average forward P/E is 11x in the Chemicals industry in South Korea. Total returns to shareholders of 112% over the past three years. Valuation Update With 7 Day Price Move • Jun 23
Investor sentiment deteriorated over the past week After last week's 16% share price decline to ₩95,000, the stock trades at a trailing P/E ratio of 4.3x. Average forward P/E is 10x in the Chemicals industry in South Korea. Total returns to shareholders of 103% over the past three years. Reported Earnings • May 22
First quarter 2022 earnings released: EPS: ₩5,352 (vs ₩4,254 in 1Q 2021) First quarter 2022 results: EPS: ₩5,352 (up from ₩4,254 in 1Q 2021). Revenue: ₩370.4b (up 43% from 1Q 2021). Net income: ₩46.7b (up 26% from 1Q 2021). Profit margin: 13% (down from 14% in 1Q 2021). Over the next year, revenue is forecast to grow 33%, compared to a 22% growth forecast for the industry in South Korea. Over the last 3 years on average, earnings per share has increased by 51% per year but the company’s share price has only increased by 33% per year, which means it is significantly lagging earnings growth. Price Target Changed • Apr 27
Price target decreased to ₩140,000 Down from ₩160,000, the current price target is provided by 1 analyst. New target price is 7.7% above last closing price of ₩130,000. Stock is up 47% over the past year. The company posted earnings per share of ₩20,907 last year. Board Change • Apr 27
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. 2 independent directors (4 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Valuation Update With 7 Day Price Move • Mar 24
Investor sentiment improved over the past week After last week's 18% share price gain to ₩113,500, the stock trades at a trailing P/E ratio of 5.4x. Average forward P/E is 12x in the Chemicals industry in South Korea. Total returns to shareholders of 150% over the past three years. Reported Earnings • Mar 12
Full year 2021 earnings: EPS in line with analyst expectations despite revenue beat Full year 2021 results: EPS: ₩20,907 (up from ₩8,773 in FY 2020). Revenue: ₩1.10t (up 23% from FY 2020). Net income: ₩182.6b (up 137% from FY 2020). Profit margin: 17% (up from 8.6% in FY 2020). Revenue exceeded analyst estimates by 4.1%. Over the next year, revenue is forecast to grow 32%, compared to a 22% growth forecast for the industry in South Korea. Over the last 3 years on average, earnings per share has increased by 53% per year but the company’s share price has only increased by 29% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Jan 26
Investor sentiment deteriorated over the past week After last week's 15% share price decline to ₩84,100, the stock trades at a trailing P/E ratio of 3.9x. Average forward P/E is 10x in the Chemicals industry in South Korea. Total returns to shareholders of 92% over the past three years. Upcoming Dividend • Dec 22
Upcoming dividend of ₩1,700 per share Eligible shareholders must have bought the stock before 29 December 2021. Payment date: 11 April 2022. Payout ratio is a comfortable 6.5% and this is well supported by cash flows. Trailing yield: 1.7%. Lower than top quartile of South Korean dividend payers (2.4%). Higher than average of industry peers (1.5%). Reported Earnings • Nov 18
Third quarter 2021 earnings released: EPS ₩4,184 (vs ₩2,635 in 3Q 2020) The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: ₩271.5b (up 27% from 3Q 2020). Net income: ₩36.5b (up 59% from 3Q 2020). Profit margin: 14% (up from 11% in 3Q 2020). Over the last 3 years on average, earnings per share has increased by 53% per year but the company’s share price has only increased by 39% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Aug 24
Investor sentiment improved over the past week After last week's 18% share price gain to ₩137,000, the stock trades at a trailing P/E ratio of 6.8x. Average forward P/E is 10x in the Chemicals industry in South Korea. Total returns to shareholders of 191% over the past three years. Valuation Update With 7 Day Price Move • Jul 23
Investor sentiment improved over the past week After last week's 32% share price gain to ₩108,500, the stock trades at a trailing P/E ratio of 9.7x. Average forward P/E is 12x in the Chemicals industry in South Korea. Total returns to shareholders of 139% over the past three years. Reported Earnings • May 20
First quarter 2021 earnings released: EPS ₩4,254 (vs ₩1,882 in 1Q 2020) The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: ₩259.6b (up 19% from 1Q 2020). Net income: ₩37.1b (up 122% from 1Q 2020). Profit margin: 14% (up from 7.7% in 1Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 36% per year but the company’s share price has only increased by 10% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Apr 20
Investor sentiment improved over the past week After last week's 15% share price gain to ₩79,900, the stock trades at a trailing P/E ratio of 9.1x. Average trailing P/E is 20x in the Chemicals industry in South Korea. Total returns to shareholders of 59% over the past three years. Is New 90 Day High Low • Mar 16
New 90-day high: ₩68,300 The company is up 47% from a price of ₩46,450 on 16 December 2020. Outperformed the South Korean market which is up 9.0% over the last 90 days. Exceeded the Chemicals industry, which is up 17% over the same period. Reported Earnings • Mar 13
Full year 2020 earnings released: EPS ₩8,773 (vs ₩7,600 in FY 2019) The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: ₩890.5b (up 1.7% from FY 2019). Net income: ₩76.9b (up 14% from FY 2019). Profit margin: 8.6% (up from 7.7% in FY 2019). Over the last 3 years on average, earnings per share has increased by 32% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth. Aankondiging • Feb 18
UNID Company Ltd., Annual General Meeting, Mar 18, 2021 UNID Company Ltd., Annual General Meeting, Mar 18, 2021, at 10:00 Korea Standard Time. Is New 90 Day High Low • Feb 05
New 90-day high: ₩56,300 The company is up 27% from its price of ₩44,400 on 06 November 2020. The South Korean market is up 26% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Chemicals industry, which is up 29% over the same period. Is New 90 Day High Low • Jan 21
New 90-day high: ₩51,400 The company is up 13% from its price of ₩45,300 on 23 October 2020. The South Korean market is up 31% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 39% over the same period. Is New 90 Day High Low • Jan 05
New 90-day high: ₩49,650 The company is up 9.0% from its price of ₩45,750 on 07 October 2020. The South Korean market is up 23% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 26% over the same period. Is New 90 Day High Low • Dec 18
New 90-day high: ₩48,800 The company is up 3.0% from its price of ₩47,450 on 18 September 2020. The South Korean market is up 14% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 18% over the same period. Is New 90 Day High Low • Oct 30
New 90-day low: ₩43,200 The company is down 10.0% from its price of ₩48,000 on 31 July 2020. The South Korean market is up 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 18% over the same period. 
